Learning outcomes
By the end of this lesson you should be able to: define infertility and state the time point at which investigation is offered; name the principal causes of infertility in women and in men; describe the timing and mechanism of the initial investigations; define the meaning and the measurement of ovarian reserve and ovulatory function; outline the initial treatment for anovulation and for a tubal factor; and counsel a couple about when assisted reproduction is indicated.
Prerequisites
Lessons 1-4. Infertility is the failure of the same anatomy and physiology that contraception deliberately interrupts.
The big idea
The definition is a probability statement, not a diagnosis: it acknowledges that a healthy couple conceives with about a twenty to twenty-five per cent chance each cycle, and that more than half of couples who have not conceived by twelve months will conceive within the following year without intervention. Its purpose is to time the investigation to the moment when further investigation becomes worthwhile, and to avoid treating a couple who would have conceived anyway.
Causes
| Category | Proportion of infertility | Causes |
|---|---|---|
| Ovulatory dysfunction | About 25 per cent | Anovulation, polycystic ovary syndrome, hyperprolactinaemia, thyroid disease, and ovarian insufficiency |
| Tubal and pelvic factors | About 20 per cent | Previous pelvic infection or chlamydial infection, endometriosis, appendicitis or surgery that leaves adhesions |
| Male factors | About 25 per cent | Reduced count or motility, varicocele, hypogonadism, and erectile dysfunction, with lifestyle factors including heat and smoking |
| Unexplained | About 25 per cent | No abnormality found on the basic tests, and the conception rate that remains is still more than a quarter per cycle |
| Uterine, cervical and other | Smaller contributions | Fibroids, endometrial polyps, cervical factors, and coital dysfunction |
Both partners are investigated, and in a substantial proportion of couples both a female and a male factor contribute. A single-factor investigation risks missing the contributing partner, which is why both investigations proceed at once rather than the female partner being investigated first and the man tested only if she is normal.
Worked example: the initial investigations
| Investigation | What it looks for | Interpretation |
|---|---|---|
| Mid-luteal progesterone | Whether ovulation has occurred | Progesterone above about 30 nanomoles per litre seven days before the next period, or on day 21 of a 28-day cycle, indicates ovulation |
| Thyroid function and prolactin | A treatable cause of anovulation | Either is raised or suppressed in a woman with anovulation or galactorrhoea |
| Day 3 follicle-stimulating hormone and oestradiol | Ovarian reserve | A raised follicle-stimulating hormone with a low oestradiol indicates reduced ovarian reserve |
| Semen analysis | The male factor | Count, motility and morphology taken after 2 to 5 days of abstinence, with two samples taken a month apart |
| Ultrasound and hysterosalpingography (or a tubal test with contrast) | Tubal patency and the uterine cavity | Contrast passing freely means the tubes are patent; hydrosalpinges or adhesions block the tube |
| Chlamydia serology | Previous pelvic infection | The commonest cause of tubal damage in the developed world |
NoteThe initial management of a couple whose investigations are normal is the same as the management of the unexplained couple: continued timed intercourse, with a reassurance that a quarter of couples conceive within the first year of investigation. Assisted conception is then considered after the appropriate interval.
Clinical correlation: treatment
Anovulation is treated according to the underlying cause. In polycystic ovary syndrome the first-line treatment is weight loss, metformin to improve insulin sensitivity where appropriate, and ovulation induction with an oral ovulatory agent such as clomifene or letrozole. In hyperprolactinaemia a dopamine agonist such as cabergoline restores ovulation by lowering prolactin. Tubal disease is not treated by drugs: the options are tubal surgery where the disease is limited, or in vitro fertilisation, which bypasses the tubes entirely.
The process of in vitro fertilisation involves superovulation with gonadotrophin stimulation, transvaginal retrieval of the oocytes, fertilisation in the laboratory and replacement of the embryo, and intracytoplasmic sperm injection is the version used where the sperm are unable to fertilise on their own. The main risks are multiple pregnancy, which is reduced by transferring a single embryo, and ovarian hyperstimulation syndrome, which is a serious and potentially fatal complication of the stimulation.
Common mistakes
Watch outSaying in vitro fertilisation treats all causes of infertility. It treats the tubal factor, the male factor, the unexplained and the ovulatory factor, but it does not treat a woman whose uterus cannot support a pregnancy, nor a male with no sperm at all without a donor.
Watch outSaying anovulation means ovarian insufficiency. Anovulation may be from polycystic ovary syndrome, thyroid disease or prolactin, and these respond to ovulation induction, whereas the ovarian insufficiency has a much poorer prognosis.
Watch outSaying a single semen analysis determines the male factor. A single abnormal sample must be repeated, because semen analysis varies with the interval of abstinence, illness, and laboratory technique.
Check your understanding
How long must a couple have been trying to conceive before they are defined as infertile?
What is the initial investigation for ovulatory function?
Why are both partners investigated simultaneously?
Multiple choice
How long must a couple have tried to conceive before they are defined as infertile?
What is the commonest cause of infertility overall?
Which progesterone value is generally accepted as evidence of ovulation?
Which is the principal risk of in vitro fertilisation?
What is the treatment of choice for bilateral tubal blockage with a hydrosalpinx?
Summary and next
Infertility is the failure to conceive after twelve months of regular unprotected intercourse, and the time point is deliberately chosen to catch the minority who will not conceive without intervention. Its causes are distributed among ovulatory dysfunction, tubal and pelvic factors, male factors and the unexplained, and the initial investigations are simple and available to a generalist: a mid-luteal progesterone for ovulation, thyroid and prolactin, a semen analysis, and a tubal test. Anovulation responds to ovulation induction, and the tubal factor is bypassed by in vitro fertilisation.